NCT01309776 Comparison of Tianeptine Versus Escitalopram Patients Major Depressive Disorder Status COMPLETED Phase PHASE4
NCT01309542 Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT01305889 The Effect of Problem Solving Therapy and Antidepressant Therapy on Cerebral Perfusion and Brain Derived Neurotropic Factor (BDNF) in Depressed Elders Status COMPLETED Phase NA
NCT01299272 A Study in Prevention of Re-emergence of Depression Symptoms Status COMPLETED Phase PHASE3
NCT01288079 A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder. Status TERMINATED Phase PHASE2
NCT01273376 Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT01269710 Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study Status COMPLETED Phase N/A
NCT01263223 A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors Status COMPLETED Phase PHASE1
NCT01263197 A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol Status COMPLETED Phase PHASE1
NCT01263093 A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel Status COMPLETED Phase PHASE1
NCT01260649 N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression Status TERMINATED Phase PHASE4
NCT01254305 Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT01250873 A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline Status COMPLETED Phase PHASE1